Evident LogoOlympus Logo

Parlez à nos experts

James Lopez
James Lopez

James Lopez

National Applications Manager

James Lopez received his Ph.D. in biomedical sciences from the University of Chicago in 2010. With nearly a decade of experience in calcium imaging, FRET, live cell imaging, and intravital imaging, James joined Olympus as a confocal and multiphoton sales representative. He later transitioned to the Olympus Life Science Applications Group, supporting confocal and multiphoton systems. Now he manages the Life Science Applications Group in the US, Canada, and Latin America markets.

Parlez à nos experts

FV3000 Red Near-Infrared (NIR) Solutions for Confocal Microscopy | 2 p.m.

Experts
James Lopez
National Applications Manager
Olympus America Inc.
In this webinar, Dr. Lopez presents the latest advances in near-infrared (NIR) confocal imaging with the Olympus FV3000 Red confocal laser scanning microscope. NIR imaging provides new opportunities for deeper imaging, more complex multiplexing, and gentler live cell imaging. Tune in to learn more about our FV3000 Red system’s unique technology providing novel NIR imaging capabilities.

FV3000 Red Near-Infrared (NIR) Solutions for Confocal Microscopy | 10 a.m.

Experts
James Lopez
National Applications Manager
Olympus America Inc.
In this webinar, Dr. Lopez presents the latest advances in near-infrared (NIR) confocal imaging with the Olympus FV3000 Red confocal laser scanning microscope. NIR imaging provides new opportunities for deeper imaging, more complex multiplexing, and gentler live cell imaging. Tune in to learn more about our FV3000 Red system’s unique technology providing novel NIR imaging capabilities.

Product Demo: FLUOVIEW™ FV3000 Confocal Laser Scanning Microscope

Experts
James Lopez
National Applications Manager
Olympus America Inc.
Join James Lopez, PhD, National Applications Manager to see how the FV3000 confocal laser microscope can expand your research possibilities and help you get more data from your samples.
InSight Blog Sign-up

By clicking subscribe you are agreeing to our privacy policy which can be found here.

Sorry, this page is not
available in your country.

Sorry, this page is not available in your country